Make an Appointment
-
Kidney Associates of Kansas City6530 Troost Avenue, Suite A, Kansas City, MO 64131 map
Dr. Gerald Reid is a nephrologist in Kansas City. He treats conditions affecting the kidneys such as renal failure, kidney stones, or chronic kidney disease.
Kidney Associates of Kansas City
Accepting New Patients?
Yes, Dr. Gerald M. Reid is accepting new patients at this office.
Phone
Fax
(816) 444-6936
Address
6530 Troost Avenue, Suite A, Kansas City, MO 64131
Office Hours
| Open | Lunch | Close | |
|---|---|---|---|
| Mon | — | ||
| Tue | — | ||
| Wed | — | ||
| Thu | — | ||
| Fri | — |
Office Details
Insurance Accepted
- Other
Bio
Dr. Gerald Reid graduated from Johns Hopkins University School of Medicine.
Dr. Reid has one office in Missouri where he specializes in Nephrology and Internal Medicine.
Dr. Reid works with seven doctors including Dr. Timothy Neufeld and Dr. Richard Muther.
Specialties
-
Nephrology
As a nephrologist in Missouri, Dr. Reid diagnoses, treats, and manages diseases and complications affecting your kidneys. These may include kidney stones, chronic kidney disease, renal failure, chronic urinary tract infections, and other disorders that affect the kidneys. When a patient's condition is serious enough to cause kidney failure, Dr. Reid may be responsible for managing the dialysis process.
-
Internal Medicine
An internist in Kansas City, MO, Dr. Gerald Reid specializes in the primary care of adults through diagnosis and treatment of cross-system illnesses that may affect multiple organic systems. Dr. Reid may also refer patients to specialists when medically needed. For example, patients experiencing severe breathing problems would be referred to a pulmonologist for further diagnostic tests or therapies.
Education & Training
Languages Spoken
- English
Latest Nephrology News
-
Kidney Disease More Deadly for MenRobert Preidt, Dec 10, 2018 at 9:00 AM
-
Kidney Disease Claiming More LivesSteven Reinberg, Dec 6, 2018 at 12:00 PM
-
Climate Change Ups Heat Deaths, Especially Among Elderly: ReportRobert Preidt, Nov 29, 2018 at 7:00 AM